|Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines||
||224||All||18 Years and older (Adult, Older Adult)||NCT00993668||RA0017||September 2009||June 2010||February 2011||October 12, 2009||August 1, 2018||June 20, 2011||
|2||NCT03056924||Active, not recruiting||Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab||
||173||All||18 Years to 75 Years (Adult, Older Adult)||NCT03056924||H-35669||July 5, 2017||December 31, 2019||December 31, 2019||February 17, 2017||July 26, 2019||
† Study has passed its completion date and status has not been verified in more than two years.